Penumbra, Inc. (PEN)

NYSE: PEN · 即時價格 · USD

318.57

-1.00 (-0.31%)

收盤價： Sep 11, 2026, 3:59 PM

317.73

+0.00%

盤後: 5:32 PM

提醒

Alert

股價、關鍵數字和最新消息，都在這一頁。

-0.31% (1D)

買價	318.78
市值	12.5B
營收 (ttm)	1.5B
淨利（ttm）	161M
	0.70
	4.07
	78.07
	51.82
P/B (ttm)	8.18
P/S (ttm)	8.32
財報日期	Nov 4, 2026

賣價	318.84
成交量	41,245
20 日平均成交量	341,001
開盤價	319.38
前收盤價	319.57
當日區間	318.38 - 319.34
52 週範圍	221.26 - 362.41
分析師	n/a
目標價	374 (17.4%)
股利	n/a
除息日	n/a

關於 PEN

Penumbra, Inc., together with its subsidiaries, designs, develops, manufactures, and markets medical devices in the United States and internationally. It offers computer-assisted vacuum thrombectomy; peripheral thrombectomy products, including the Indigo System for power aspiration of thrombus in the body; Lightning Flash, a mechanical thrombectomy system; Lightning Bolt 7, an arterial thrombectomy system; and CAT RX. It also provides access prod...

[閱讀更多]

產業 Medical Devices

類股 Healthcare

IPO 日期 Sep 18, 2015

員工 4,700

證券交易所 NYSE

股票代號 PEN

網站 https://www.penumbrainc.com

完整的公司簡介

財務表現

Penumbra 在 2025 年的營收為 1.4B，較前一年的 1.19B 增加 17.5%。淨利為 177.69M，較前期增加 1,168.11%。

財務報表

分析師預測

根據 12 位分析師的評等，PEN 的平均評等為「null」。12 個月目標價為 374，較最新價格有 17.4% 的上漲空間。

股票預測

財報驚奇

Penumbra 已於 Jul 30, 2026 公布季度財報：

營收為 $390.05M 低於預期 $0, 年增 14.90% 成長.
每股盈餘為 1.01 低於預期 -0.17, 年增 17.44% 成長.

下次財報發布

Penumbra, Inc. 的下次財報預計於 Nov 4, 2026, 盤中。
分析師預估營收 ... 升級

價格為何變動

新聞動態

2 週前 · Zacks

TFX or PEN: Which Is the Better Value Stock Right Now?

TFX vs. PEN: Which Stock Is the Better Value Option?

4 週前 · Trefis

Which Medtech Giant Would Buy Inspire Medical Systems?

The market may be focused on temporary hurdles, but a strategic acquirer would see a unique technology at a strong price.

1 月前 · Zacks

TFX vs. PEN: Which Stock Is the Better Value Option?

1 月前 · Zacks

Is ANGO a Buy as Med Tech Growth Battles Persistent Margin Pressure?

AngioDynamics' Med Tech growth and reimbursement gains strengthen its outlook, but tariffs, rising costs and execution risks keep the buy case uncertain.

1 月前 · Simply Wall St.

Penumbra (PEN) Following THUNDERBOLT Debut, Is The Stock A Bargain Or Fairly Valued

Penumbra (PEN) is back in focus after Novant Health reported successful use of its newly cleared THUNDERBOLT computer assisted vacuum thrombectomy system at a North Carolina comprehensive stroke cente...

第 1 頁，共 2 頁

Penumbra, Inc. (PEN)

Penumbra, Inc.（PEN）股價、分析與資料

關於 PEN

財務表現

分析師預測

財報驚奇

下次財報發布

價格為何變動

新聞動態

2 週前 · Zacks

4 週前 · Trefis

1 月前 · Zacks

1 月前 · Zacks

1 月前 · Simply Wall St.